We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
The European Centre for Disease Prevention & Control (ECDC) reports continued transmission of measles in Europe. From 1 January 2024 to 16 August 2024, countries reporting cases are:
Austria: 490 cases
Belgium: 275 cases
Bulgaria: 24 cases
Croatia: 18 cases
Czech Republic: 30 cases
Denmark: 20 cases
France: 300 cases
Germany: 399 cases
Ireland: 82 cases (1 death)
Italy: 807 cases
Netherlands: 147 cases
Norway: 9 cases
Poland: 246 cases
Portugal: 34 cases
Romania: 19 785 cases (18 deaths)
Spain: 181 cases
Sweden: 23 cases
Measles is highly contagious and continuing transmission means there is also risk of spread to countries not currently reporting cases.
Travel may increase an individual’s risk of exposure to measles virus, and facilitate the spread of disease to unvaccinated and susceptible populations. The travel consultation provides a valuable opportunity to ensure individuals are protected against measles, mumps and rubella (MMR) viruses. Two doses of MMR vaccine, at least one month apart, are required to give adequate protection.
Consider vaccinating:
For children, first and second doses of MMR vaccine can be administered earlier than they would routinely be given within the UK Vaccination Schedule (2 doses of MMR vaccine around 12-13 months, and before starting school at around 3 years 4 months of age).
See the TRAVAX Measles, Mumps and Rubella page for further information.